Related Image: Allsup Finds Healthcare Costs Consuming Larger Part of Fixed Incomes |
(Date:7/2/2009)...LITTLE SILVER, N.J., July 2 Dr Dan... is coordinating a new study to measure the effect...ent of acute EKC -- a common, worldwide, highly co...ith the potential for long term visual impairment ...s around the world are invited to register to part...
(Date:7/2/2009)...PHILADELPHIA, July 2 A ...Italy per 100,000 women between the ages of 0 to 8... official estimates issued by the Ministry of Heal...d in the youngest group studied (ages 25 to 44). ,...on databases that track major breast surgeries rat...
(Date:7/2/2009)...y explores weight problems faced by youngsters wit...thDay News) -- Children with type 1 diabetes are m... disease, increasing their risk of serious health ...s from a major study that explored the weight prob..., a less common form of the disease that usually s...
(Date:7/2/2009)...rtain mutations in the DNA of the hepatitis B viru...er cancer and may help predict which patients with...se, according to a large meta-analysis in the Jou...online July 2. , HBV infection is a known cause ... form of liver cancer. Previous studies have looke...
Breaking Medicine News(10 mins):Health News:Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study 2Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 2Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 3Health News:Kids With Type 1 Diabetes Often Overweight 2(Date:6/30/2009)...ZER, Pa., June 30 Cephal... has submitted a supplemental New Drug Application...FDA) requesting approval of NUVIGIL(R) (armodafini...akefulness in patients with excessive sleepiness a...tbound travel. Jet lag disorder is an acute condi...
(Date:6/29/2009)...dy in major abdominal surgery patients achieved pr... Calif., June 29 AcelRx Pharmaceut...the second Phase 2 clinical study evaluating the s...bs(TM) for the management of acute post-operative ... hospitalization. Compared to placebo, patients re...
(Date:6/28/2009)... CHIPPENHAM, England and TOKYO, June 29 /PRNewswir...or Both Companies , Sosei Group Corporation...roup plc ("Vectura"; LSE: VEC) announce the commen... with NVA237, a once-daily, long-acting muscarinic...bstructive pulmonary disease,(COPD). NVA237 is a ...
(Date:6/26/2009)...itive Opinion Recommends Approval of New Anti-TNF ...rtJect(TM) Autoinjector , , HORSHAM, Pa. and KE...Centocor Ortho Biotech Inc. and Schering-Plough Co...Committee for Medicinal Products for Human Use (CH...d a positive opinion recommending the approval of ...
Breaking Medicine Technology:Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 2Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 3Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder 4AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10Scientists measure connection between the built environment and obesity in baby boomers 25268 1Scientists measure connection between the built environment and obesity in baby boomers 25268 2The Childrens Hospital of Philadelphia Receives Grant to Study Tailoring Pediatric Preventive Care to Individual Needs 25265 1The Childrens Hospital of Philadelphia Receives Grant to Study Tailoring Pediatric Preventive Care to Individual Needs 25265 2The Childrens Hospital of Philadelphia Receives Grant to Study Tailoring Pediatric Preventive Care to Individual Needs 25265 3Mergent Inc Announces Changes to the HealthShares 28TM 29 European Drugs Index 7073 1Mergent Inc Announces Changes to the HealthShares 28TM 29 European Drugs Index 7073 2Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide 25261 1Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide 25261 2Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide 25261 3...L, Wash. & LOS ANGELES--(BUSINESS WIRE)--Apr 1...day announced data from,fifteen presentations by t...l Meeting of the American Association for Cancer R...with its proprietary,antibody-drug conjugate (ADC)... monoclonal antibodies linked to cell-killing drug...
...GH, N.C., April 18, 2007 /PRNewswire/ -- Micell,Te...e presenting,data on use of its supercritical flui...luting stents at the upcoming Society for,Biomater...ago,Illinois. , The abstracts describe use of Mic...ESS technology to create drug-eluting stents,conta...
Other Medicine Technology:Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 2Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 3Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 4Micell Technologies Presents Data on Novel Drug-Eluting Stents 2Micell Technologies Presents Data on Novel Drug-Eluting Stents 3...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: